{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:50:50Z","timestamp":1788288650133,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.neurol.2023.10.011","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T12:42:42Z","timestamp":1702384962000},"page":"101-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Management of lower urinary tract symptoms in Parkinsonian disorders"],"prefix":"10.1016","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3948-7544","authenticated-orcid":false,"given":"C.","family":"Guillot-Tantay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2023.10.011_bib0210","series-title":"International Continence Society fact sheets [Internet]","year":"2015"},{"key":"10.1016\/j.neurol.2023.10.011_bib0215","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/nau.22764","article-title":"A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders","volume":"35","author":"Sakakibara","year":"2016","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.neurol.2023.10.011_bib0220","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ucl.2017.04.008","article-title":"Parkinson's disease and its effect on the lower urinary tract: evaluation of complications and treatment strategies","volume":"44","author":"Brucker","year":"2017","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.neurol.2023.10.011_bib0225","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.parkreldis.2016.10.024","article-title":"Lower urinary tract symptoms in Parkinson's disease: prevalence, aetiology and management","volume":"35","author":"McDonald","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2023.10.011_bib0230","doi-asserted-by":"crossref","first-page":"106885","DOI":"10.1016\/j.clineuro.2021.106885","article-title":"Characteristics and risk factors of lower urinary tract dysfunction in patients with Parkinson's disease: A systematic evaluation and meta-analysis","volume":"209","author":"Zhuang","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.neurol.2023.10.011_bib0235","doi-asserted-by":"crossref","first-page":"e0193783","DOI":"10.1371\/journal.pone.0193783","article-title":"Increased risk of overactive bladder in patients with idiopathic Parkinson's disease: insight from a nationwide population-based cohort study","volume":"13","author":"Lin","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2023.10.011_bib0240","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/nau.23976","article-title":"Investigation of urinary storage symptoms in Parkinson's disease utilizing structural MRI techniques","volume":"38","author":"Roy","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.neurol.2023.10.011_bib0245","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jon.12829","article-title":"Regional cerebral cortical atrophy is related to urinary tract symptoms in Parkinson's disease","volume":"31","author":"Roh","year":"2021","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.neurol.2023.10.011_bib0250","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0022-5347(17)51929-1","article-title":"Neurourologic findings in Parkinson's disease","volume":"129","author":"Pavlakis","year":"1983","journal-title":"J Urol"},{"key":"10.1016\/j.neurol.2023.10.011_bib0255","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3233\/JPD-191806","article-title":"Assessment and management of urinary dysfunction in 187 patients with Parkinson's disease","volume":"10","author":"Jia","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.neurol.2023.10.011_bib0260","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.purol.2012.12.004","article-title":"Lower urinary tract dysfunctions in parkinsonian syndromes: a review by the Neuro-Urology Comittee of the French Association of Urology","volume":"23","author":"Ph\u00e9","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.neurol.2023.10.011_bib0265","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0022-5347(05)67048-6","article-title":"Voiding dysfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms","volume":"164","author":"Araki","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.neurol.2023.10.011_bib0270","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1007\/s10072-021-05411-y","article-title":"Lower urinary tract dysfunction in Parkinsonian syndromes","volume":"42","author":"Vichayanrat","year":"2021","journal-title":"Neurol Sci"},{"key":"10.1016\/j.neurol.2023.10.011_bib0275","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/mds.870120406","article-title":"Urinary disturbances in striatonigral degeneration and Parkinson's disease: clinical and urodynamic aspects","volume":"12","author":"Bonnet","year":"1997","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2023.10.011_bib0280","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/nau.20461","article-title":"Urinary and erectile dysfunction in multiple system atrophy (MSA)","volume":"27","author":"Papatsoris","year":"2008","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.neurol.2023.10.011_bib0285","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/mds.20586","article-title":"Sonographic assessment of urinary retention in multiple system atrophy and idiopathic Parkinson's disease","volume":"20","author":"Hahn","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2023.10.011_bib0290","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/mdc3.13307","article-title":"Urodynamic evaluation in multiple system atrophy: a retrospective cohort study","volume":"8","author":"Eschlb\u00f6ck","year":"2021","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.neurol.2023.10.011_bib0295","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.parkreldis.2014.12.003","article-title":"Impaired detrusor contractility is the pathognomonic urodynamic finding of multiple system atrophy compared to idiopathic Parkinson's disease","volume":"21","author":"Kim","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2023.10.011_bib0300","doi-asserted-by":"crossref","first-page":"e946","DOI":"10.1212\/WNL.0000000000008053","article-title":"Urodynamic study for distinguishing multiple system atrophy from Parkinson disease","volume":"93","author":"Shin","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.10.011_bib0305","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.2169\/internalmedicine.8724-21","article-title":"Female urinary retention progressing to possible multiple system atrophy-cerebellar form after 12 years","volume":"61","author":"Sakakibara","year":"2022","journal-title":"Intern Med"},{"key":"10.1016\/j.neurol.2023.10.011_bib0310","first-page":"65","article-title":"Comparative effectiveness of anticholinergic agents for lower urinary tract symptoms","volume":"24","author":"Goodson","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.neurol.2023.10.011_bib0315","first-page":"307","article-title":"Agents for treatment of overactive bladder: a therapeutic class review","volume":"20","author":"Hesch","year":"2007","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.neurol.2023.10.011_bib0320","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.eururo.2010.10.046","article-title":"Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe","volume":"59","author":"Chapple","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.neurol.2023.10.011_bib0325","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/mds.870100318","article-title":"Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease","volume":"10","author":"Suchowersky","year":"1995","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2023.10.011_bib0330","doi-asserted-by":"crossref","first-page":"e034887","DOI":"10.1136\/bmjopen-2019-034887","article-title":"Stimulation of the tibial nerve: a protocol for a multicentred randomised controlled trial for urinary problems associated with Parkinson's disease-startup","volume":"10","author":"McClurg","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.neurol.2023.10.011_bib0335","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.purol.2019.02.006","article-title":"Results and compliance of transcutaneous tibial nerve stimulation on overactive bladder syndrome in patients with Parkinson's disease. Retrospective study","volume":"29","author":"Charvolin","year":"2019","journal-title":"Prog Urol"},{"key":"10.1016\/j.neurol.2023.10.011_bib0340","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.urology.2021.01.044","article-title":"The sustained therapeutic effects of percutaneous posterior tibial nerve stimulation in the treatment of neurogenic lower urinary tract symptoms in patients with Parkinson's disease: 24-month clinical and urodynamic results","volume":"153","author":"Kabay","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.neurol.2023.10.011_bib0345","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/WON.0000000000000078","article-title":"Transcutaneous tibial nerve stimulation in the treatment of lower urinary tract symptoms and its impact on health-related quality of life in patients with Parkinson disease: a randomized controlled trial","volume":"42","author":"Perissinotto","year":"2015","journal-title":"J Wound Ostomy Continence Nurs"},{"key":"10.1016\/j.neurol.2023.10.011_bib0350","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.annfar.2011.02.012","article-title":"Anaesthesia and Parkinson's disease","volume":"30","author":"Chhor","year":"2011","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.neurol.2023.10.011_bib0355","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.neurom.2022.01.019","article-title":"Neuromodulation for storage lower urinary tract symptoms in Parkinson disease: a\u00a0systematic review","volume":"25","author":"Smith","year":"2022","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neurol.2023.10.011_bib0360","doi-asserted-by":"crossref","first-page":"96e1","DOI":"10.1016\/j.ajog.2007.04.016","article-title":"Sacral nerve neuromodulation in patients with underlying neurologic disease","volume":"197","author":"Wallace","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.neurol.2023.10.011_bib0365","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.juro.2011.04.071","article-title":"Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder","volume":"186","author":"Giannantoni","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.neurol.2023.10.011_bib0370","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12894-016-0174-2","article-title":"Preserved micturition after intradetrusor onabotulinumtoxinA injection for treatment of neurogenic bladder dysfunction in Parkinson's disease","volume":"16","author":"Kn\u00fcpfer","year":"2016","journal-title":"BMC Urol"},{"key":"10.1016\/j.neurol.2023.10.011_bib0375","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.purol.2017.11.004","article-title":"Self-intermittent-catheterization and urinary retentions in Parkinsonian syndromes","volume":"28","author":"Savard","year":"2018","journal-title":"Prog Urol"},{"key":"10.1016\/j.neurol.2023.10.011_bib0380","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.purol.2021.01.004","article-title":"Intradetrusor injections of botulinum toxin A to treat urinary incontinence due to bladder overactivity during idiopathic Parkinson's disease","volume":"31","author":"Atamian","year":"2021","journal-title":"Prog Urol"},{"key":"10.1016\/j.neurol.2023.10.011_bib0385","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.euf.2022.05.004","article-title":"Effects of deep brain stimulation on lower urinary tract function in neurological patients","volume":"8","author":"Sartori","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.neurol.2023.10.011_bib0390","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/mds.21253","article-title":"Lower urinary tract symptoms and bladder control in advanced Parkinson's disease: effects of deep brain stimulation in the subthalamic nucleus","volume":"22","author":"Winge","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2023.10.011_bib0395","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4081\/aiua.2022.1.107","article-title":"Perspectives on the urological care in Parkinson's disease patients","volume":"94","author":"Moussa","year":"2022","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.neurol.2023.10.011_bib0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prnil.2023.01.002","article-title":"Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures","volume":"11","author":"Franco","year":"2023","journal-title":"Prostate Int"},{"key":"10.1016\/j.neurol.2023.10.011_bib0405","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/nau.20978","article-title":"Clinical relevance of urethral stents (Urospiral 2\u2122) placement in patients with prostatic obstacle and concomitant high-risk surgical status or neurological diseases: a feasibility and safety study","volume":"30","author":"Roupr\u00eat","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.neurol.2023.10.011_bib0410","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/nau.23496","article-title":"Neurogenic bladder in progressive supranuclear palsy: a comparison with Parkinson's disease and multiple system atrophy","volume":"37","author":"Kim","year":"2018","journal-title":"Neurourol Urodyn"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378723011402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378723011402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:46:58Z","timestamp":1758520018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378723011402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":41,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0035378723011402"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2023.10.011","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of lower urinary tract symptoms in Parkinsonian disorders","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2023.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}